Mutations in peripherin 2 (PRPH2, also known as Rds), a tetraspanin protein found in photoreceptor outer segments (OSs), cause retinal degeneration ranging from rod-dominant retinitis pigmentosa (RP) to cone-dominant macular dystrophy (MD). Understanding why some Prph2 mutants affect rods while others affect cones remains a critical unanswered question. Prph2 is essential for OS structure and function and exhibits a very specific pattern of oligomerization with its homolog Rom1. Noncovalent Prph2/Rom1 homo-and hetero-tetramers assemble into higher-order covalently linked complexes held together by an intermolecular disulfide bond at Prph2-C150/Rom1-C153. Here we disrupt this crucial bond using a C150S-Prph2 knockin mouse line to study the role of Prph2 higher-order complex formation. We find that C150S-Prph2 traffics to the OS, interacts with Rom1 and forms non-covalent tetramers, but alone cannot support normal OS structure and function. However, C150S-Prph2 supports the initiation or elaboration of OS disc structures, and improves rod OS ultrastructure in the presence of wildtype (WT) Prph2 (i.e. Prph2 C150S/þ versus Prph2
Introduction
Over 150 different pathogenic mutations in the photoreceptorspecific gene PRPH2 (also known as RDS or retinal degeneration slow) have been described in patients, leading to a variety of phenotypes spanning from MD to RP (1) . PRPH2 and its homolog ROM1 are critical for the formation of the disc rim region of rod and cone photoreceptor outer segments (OSs) (2) (3) (4) . Prph2 and Rom1 create and maintain the rim region of rod discs and cone lamellae and help to regulate disc size and alignment. Data thus far show that both of these processes are dependent on the formation of specific types of Prph2 and Rom1 complexes (5-7). The two proteins initially form homomeric and heteromeric tetramers mediated by non-covalent interactions in the second extracellular/intradiscal (D2) loop (8) (9) (10) . All tetraspanin proteins, including Prph2 and Rom1 have intramolecular disulfide bonds to stabilize the structure of the D2 loop (11, 12) ; however, Prph2 and Rom1 each also have an additional D2 loop cysteine not involved in intramolecular disulfide bonding. This cysteine (C150 in Prph2 and C153 in Rom1) is involved in intermolecular disulfide bond formation and mediates assembly of Prph2/Rom1 tetramers into covalently linked higher-order complexes (5, 10, 12) .
To understand the importance of C150-mediated complex assembly for OS structure and function, we previously used transgenic mouse models expressing oligomerization-incompetent (C150S) Prph2 in either rods (under the control of the mouse opsin promoter-MOP-T) or in cones (under the control of the cone opsin promoter-COP-T). Although C150S-Prph2 formed tetramers, it did not form higher-order oligomers and did not support OS formation. Importantly, C150S Prph2 led to a dominantnegative defect specifically on cone function and protein targeting (5, 13) . This finding suggested that Prph2/Rom1 complex formation may be differentially involved in the two cell types. Working out cone versus rod differences in Prph2 complex formation and behavior is central to understanding why some Prph2 mutants lead to rod-dominant disease while others lead to cone dominant disease. The C150S mutation is an essential structure-function model for this purpose, but our results were severely limited in their applicability because transgenic mouse models have uncontrolled levels of expression. This is critical both because Prph2 haploinsufficiency results in severe defects (14, 15) independent of any mutation and because it is not possible to ensure that the MOP-T and COP-T promoters drive expression equally or in the same manner as the endogenous gene.
To overcome limitations of transgenic models, here we generated and evaluated a C150S knockin model. We confirm that C150S Prph2 leads to dominant-negative defects in cone but not in rod function, in spite of being trafficked properly to the OS. Interestingly, we find structural but not functional improvement in C150S heterozygous rods, suggesting that the Prph2 higher-order oligomers have roles beyond being simple structural components. We also utilize another Prph2 model (Y141C) to specifically evaluate the effects of the addition of a Prph2 allele with an extra cysteine and found that again rods and cones behave differently. These findings significantly refine and advance our understanding of the molecular defects underlying Prph2-associated pathologies and provide insight into the structural regulation of rod and cone photoreceptors.
Results

C150S does not support OS structure and leads to dominant-negative functional defects in cones
To eliminate the effects of variable levels of transgene expression, we generated a knockin mouse model carrying the C150S mutation in the Prph2 locus (Supplementary Material, Fig. S1 ). To determine what effect this mutation had on retinal structure and function, we began by conducting light microscopy and electron microscopy (EM) analyses at postnatal day (P) 30 on retinas from C150S homozygous (Prph2 C/C ) and heterozygous knockin mice (Prph2 C/þ ). Overall retinal lamination was not altered in mice carrying the C150S allele (Fig. 1A) , and outer nuclear layer (ONL) thinning (owing to photoreceptor degeneration) was not evident; in contrast Prph2 À/À retinas at this age already showed reduction in ONL thickness (Fig. 1A , $9-10 rows of photoreceptor nuclei in Prph2
Prph2
C/þ and Prph2 C/C and $6 rows in Prph2
). Examination by EM, however, revealed gross OS malformation in the Prph2 C/C retina ( Fig. 1B and C; Supplementary Material, Fig. S2A ). In contrast to the nicely stacked discs and elongated OSs of the WT, the Prph2 C/C exhibited highly disorganized, very short OSs with elongated discs curving around into whorl-like structures that were nonetheless an improvement over the complete lack of OSs seen in the Prph2
. Prph2 C/C OSs were similar in structure but smaller than those seen in the haploinsufficient Prph2 þ/À . To understand whether these small structures were cones or rods (or both), we identified cone OSs by immunogold (IG) labeling at the EM level with anti-S-opsin antibodies (Fig. 1D) , and found that cone OSs in the Prph2 C/C were structurally similar to rod OSs; namely they were quite small and exhibited whorl-like disc structures. C150S heterozygous animals also showed abnormal OSs, characterized by elongated, disorganized discs and vesicle-like structures (arrow in Fig. 1C ). Importantly, although some OSs in the Prph2 C/þ were still abnormal, most OSs were improved in ultrastructure when compared with the Prph2 þ/À ( Fig. 1C; Supplementary Material, Fig. S2B ). These improvements included better disc stacking, orientation, and size, as well as reduction in the whorl-like phenotype seen in the Prph2 C/C and the Prph2 þ/À . To evaluate the effects of the C150S allele on retinal function, full-field scotopic and photopic electroretinograms (ERGs) were performed at P30 and P60 ( Fig. 2A) . Mean scotopic a-and bwave ERG amplitudes in Prph2 C/þ were significantly decreased by 50% (a-wave) or 30% (b-wave), respectively, when compared with WT, and were similar to those found in Prph2
suggesting that C150S acts as a loss-of-function allele in rods.
To evaluate cone function, we measured photopic ERG responses (Fig. 2C ). C150S heterozygous animals exhibited mean photopic responses $25% lower than those in Prph2
(which is normal at P30), suggesting that the C150S allele has dominant-negative or gain-of-function effects in cones, consistent with our previous findings (5) . Rod and cone function in the Prph2 C/þ did not change from P30 to P60, suggesting these retinas did not undergo rapid degeneration. Scotopic function in the Prph2 C/C was slightly better than in the Prph2 À/À retina at P30, reaching $25% of the WT levels, indicating that the small OSs we observed in these retinas were capable of phototransduction. However, rod function in the Prph2 C/C decreased at P60 suggesting these abnormal OSs may progressively degenerate (Fig. 2B) . Cone function was not as affected as rod function in the Prph2 C/C , reaching 40% of WT at P30 (Fig. 2C ). Combined these data indicate that C150S alone is not sufficient to support proper OS structure and function in rods or cones. In addition, we find that cones are adversely affected by C150S, even when WT Prph2 is also present.
The C150S mutation alters Prph2 protein levels and has a profound influence on Prph2 oligomerization
We next evaluated the molecular mechanism underlying the structural and functional defects associated with the C150S mutation, and our first step was to compare expression levels from the knockin allele to that of the WT allele. We evaluated transcript levels by qRT-PCR at P 10, 20 and 30 (time points that reflect OS development) and found that Prph2 and Rom1 transcript levels in Prph2 C/C retinas were not different from WT at any time points (Fig. 3A) . In addition, co-localization studies showed that C150S protein was in the OSs of both rods and cones in the Prph2 C/C (Supplementary Material, Fig. S3 ). Combined these findings suggest that the mutation did not affect gene regulation and that expression from the knockin allele was properly regulated. In contrast, we found Prph2 and Rom1 protein levels were significantly decreased in the Prph2 C/C retinas. Because cones make up 3-5% of photoreceptors in the WT retina, we assessed the effect of mutant Prph2 on total levels of Prph2 and Rom1 in retinas on WT (rod-dominant) and Nrl À/À (cone-dominant) (16) backgrounds to help understand differences in the two cell types. Prph2 protein levels in Prph2 C/C retinas were only 7% of Fig. 3B and C), while Prph2 levels in the Prph2
were reduced even further, to 1% of those in the Nrl À/À ( Fig. 3D and E). Decreases in Prph2 protein levels are frequently associated with a corresponding decrease in Rom1 levels (5, 8, 17, 18) , a finding recapitulated here; Rom1 levels in Prph2 C/C were $10% of WT ( Fig. 3B and C) . Interestingly, decreases in Rom1 associated with C150S were much less pronounced in the cone-dominant background: Rom1 levels in the Prph2 C/C Nrl À/À were 70% of those in the Nrl À/À ( Fig. 3D and E) . This relative preservation of Rom1 in cones does not appear to be owing to enhanced stability of Rom1 in cones in the absence of Prph2 per se, as Rom1 levels in the Prph2 À/À Nrl À/À retina were very low, similar to levels in the
Prph2-associated macular disease is autosomal dominant, and patients are heterozygous for disease-causing mutations (1) . Thus, understanding to what extent mutations affecting complex formation (such as C150S) can exert effects in the presence of the WT protein is critical. Since the only difference between the WT and mutant Prph2 is the conversion of cysteine at position 150 to serine, we are not able to distinguish between these 2 proteins in the heterozygous C150S retinas. We, therefore, evaluated total Prph2 levels in these retinas. C150S heterozygous animals on the WT (rod-dominant) background had reduced total Prph2 protein levels compared with WT ( Fig. 3B  and C ), yet much higher levels than in the Prph2 þ/À retina. This is recapitulated in cones, as mean levels of Prph2 in the Prph2
Nrl À/À retina were not statistically significantly different from Nrl À/À and were higher than those in the Prph2 Fig. 3D and E). Rom1 levels were not significantly affected in heterozygous animals in the WT or Nrl À/À background. To independently evaluate C150S-Prph2 from the WT-Prph2 in the Prph2 C/þ retina, we crossed C150S knockin mice with N229S
Prph2 knockin mice. We previously showed that the N229S mutation does not affect OS structure, retinal function, or Prph2/Rom1 complex assembly at early timepoints (18) , and since it abolishes Prph2 glycosylation, N229S-Prph2 can be distinguished from WT or C150S Prph2 by virtue of its smaller size. In Prph2 C/N retinas, overall Prph2 levels were $75% of WT (similar to the Prph2 C/þ as expected) with the C150S Prph2 accounting for $25% (Fig. 3F ).
In the retina, WT Prph2 assembles into various homomeric and heteromeric (with Rom1) complexes held together by both disulfide-linkages as well as non-covalent bonds, and was thus present as both a monomer and disulfide-linked dimer under non-reducing conditions ( Fig. 3B and D) . In contrast, Prph2 in the Prph2 C/C and Prph2 , confirming the ability of Rom1 to form covalently linked homomeric complexes (17) , however, no Rom1 dimer was found in the Prph2
may be involved in different types of complexes in rods versus cones.
To evaluate interactions between C150S and WT Prph2 in the Prph2 C/C retina, we performed reciprocal co-immunoprecipitation (IP). In work using the COP-T transgenic line on the Prph2
background we previously observed that C150S protein in cones (but not rods) did not pull down Rom1 (5, 13) . However, here we do not find this cone versus rod difference; we see that C150S Prph2 pulled down Rom1 from Prph2 C/C and Prph2 was detected in fractions associated with higher order complexes (1-3), and no C150S Prph2 was detected in fractions 1-3 ( Fig. 4F ). This finding suggests that C150S Prph2 does not participate in covalently linked complexes with WT Prph2 (consistent with the lack of cysteine responsible for intermolecular disulfide bonding) and also that C150S Prph2 impairs the ability of WT Prph2 to assemble into larger oligomers. To confirm that this was a gain-of-function/dominant negative effect rather than simply an outcome of potential C150S loss-of-function, we evaluated Prph2/Rom1 complex assembly in the Prph2 þ/À and found that large oligomers (Fractions 1-3) do assemble normally in this model (Fig. 4G) . The Prph2 C/N retina also exhibited a subtle right shift in the distribution of Rom1-containing complexes corresponding to fewer intermediate sized complexes and more tetrameric complexes (Fig. 4F) . The shift in complex size between the Prph2 C/C and the Prph2 C/N (i.e. Fig. 4D versus Fig. 4F ) suggests that the mutant protein is able to incorporate into non-covalently linked complexes with WT Prph2, but that overall, C150S suppresses the formation of larger disulfide linked Prph2 complexes. Given the defects in assembly of larger sized complexes in Prph2 C/C retinas, we asked whether the mutant protein was capable of localizing properly to the OS using IG labeling for Prph2 (Fig. 5A ) followed by EM. In the WT retina, Prph2 and Rom1 ( Fig. 5A and B) properly localized to the rim region of the OS discs (arrows), while rhodopsin was found throughout the disc (Fig. 5C ). This localization was preserved in the Prph2 C/C even though the disc structure was highly disorganized, with C150S Prph2 and Rom1 found at the rims of the discs (Fig. 5A , right three panels and Fig. 5B , right panel) and rhodopsin distributed throughout (Fig. 4C, right panel) . These findings indicate that even in the absence of higher-order Prph2 complexes, the innate organization of the disc with its distinct protein distribution is preserved in the Prph2 C/C retina and that C150S Prph2 retains the ability to target to the OS.
Heterogeneous complexes in a Prph2
C/Y double knockin mouse lead to rescue of cone but not rod function
One benefit of the C150S knockin allele is that we can use it to further our understanding of disease mechanisms in other Prph2-disease causing mutants such as that of the Y141C. The Y141C mutation has been of recent interest to us because it is associated with widely varying phenotypes in patients, some of whom present with milder forms of pattern dystrophy while others exhibit more severe RP. The Y141C knockin mouse line (Prph2
) exhibits dominant gain-of-function defects in cones and equal amounts of total proteins were loaded on non-reducing SDS-PAGE gels and blots were probed for Prph2 (RDS-CT) and Rom1 (2H5) to show the monomeric and dimeric (disulfide-linked) forms of Prph2 and Rom1. (C, E) Protein levels in retinal extracts were calculated densitometrically and normalized to corresponding actin values. Prph2 and Rom1 dimers and monomers were quantified separately. (F) Retinal extracts from Prph2 C/N animals and controls were separated under non-reducing (left) and reducing (right) conditions. Levels of Prph2 were calculated densitometrically from reducing blots where the size shift owing to the lack of glycosylation on the N229S protein can be easily visualized and normalized to actin. Graphs plot mean total Prph2 and Rom1 levels (i.e. dimerþmonomer)6SEM, n ¼ 5 retinas/group. *P < 0.05, ***P < 0.001, ****P < 0.0001 for one-way ANOVA with Tukey's post hoc test. (Fig. 6A, arrows) , however, it completely lack dimers, in common with the Prph2 C/C (Fig. 6A, arrowheads) .
Co-expression of C150S and Y141C protein (Prph2 ; all three genotypes exhibited Prph2 levels $10-15% of WT. To further evaluate complex formation in these animals, we conducted non-reducing velocity sedimentation and separated gradient fractions on non-reducing gels. Prph2 was found in two broad pools in the Prph2 C/Y , a pool of disulfide linked abnormally large complexes in Fractions 1-3 and a pool of noncovalently linked tetramers in Fractions 6-9 (Fig. 6B) . No Prph2 complex containing a single disulfide bond (i.e. dimers) was detected nor were any intermediate-sized (Fractions 4-5) complexes were detected. Again, this pattern is a combination of that seen in the Prph2 Y/Y (Fig. 6B ) (17) and that seen in the Prph2 C/C (Fig. 6B ).
To determine whether this distribution of Prph2 complexes had the ability to support retinal function, we performed ERG on Prph2 C/Y animals and controls (Fig. 6C , controls are replotted from Fig. 2 for comparison) . Based on the abnormal complex assembly in the Prph2 
Discussion
As previously reported, here we find that C150S-Prph2 alone cannot support full OS formation, yet can form small nascent OS structures. Prph2 C/C retinas do not exhibit the typical ONL thinning that characterizes the Prph2 À/À at P30, suggesting that formation of even tiny OS structures can help delay photoreceptor cell death. From a functional standpoint, Prph2 C/þ retinas exhibit a haploinsufficiency phenotype in rods and a dominantnegative phenotype in cones. Importantly, the C150S-Prph2 does traffic properly to the OSs of rods and cones and retains the ability to interact with Rom1 and form non-covalently linked tetramers. The primary molecular defect of C150S Prph2 is an inability to form covalently linked complexes (5, 12) , and the severe structural and functional defects in the Prph2 C/þ and Prph2 C/C retinas clearly demonstrate the essential role for these large covalently-linked Prph2 complexes in proper OS morphogenesis. Importantly, although C150S is not a mutation found in patients with Prph2-associated disease, many patient mutations, including K153del, cause phenotypes that are quite similar to C150S (20) . Structurally, we observe that Prph2 C/C retinas exhibit very small whorl-like OSs that are nonetheless capable of low amounts of phototransduction. These small OSs were reminiscent of those seen in previous Prph2 disease models such as the Y141C and the K153del in which the mutation alters complex formation (17, 20) . These data suggest that even though Prph2 and Rom1 levels are only at $10% of WT levels, the small amount of tetrameric Prph2 present in the Prph2 C/C is able to initiate OS formation. Likewise these findings suggest that properly formed large Prph2 oligomers are not needed for initiation of disc formation, but are required for proper disc sizing, alignment, rim pinching and OS lengthening. This is consistent with recent work showing that Prph2 plays a role in the initiation of disc formation by suppressing ectosome release at the connecting cilium, and may be involved in mediating membrane curvature. These functions reside in the C-terminus of Prph2 (21-23), and thus would be intact in the various D2 loop mutants (C150S, K153del and Y141C) that exhibit altered Prph2 complex formation but still initiate discs formation.
One of the critical advantages of using a knockin model (versus a transgenic) is that we confirmed that gene expression of the mutant allele on the mRNA level is similar to that of WT. In spite of this, Prph2 C/C animals have protein levels only $10% of WT levels, suggesting that the C150S protein is rapidly degraded. It is possible that the C150S protein is inherently more unstable than WT Prph2, but it is also possible that in the absence of fully elaborated and elongated OSs, there is simply no place for the normal complement of Prph2 to reside. This latter explanation also may account for the comparable reduction we observed in Rom1 levels in Prph2 C/C retinas and is consistent with our previous observation that Rom1 and rhodopsin levels are often reduced in Prph2 mutants that have abnormal OSs (17, (24) (25) (26) . On the other hand, we find cones do not follow this pattern precisely. C150S-Prph2 levels in cones (i.e. Prph2 ), yet Rom1 levels are well preserved. This rod-cone divergence in the way Rom1 responds to variations in Prph2 suggests that rods and cones process and utilize Prph2 and Rom1 in different ways. This rod-cone difference is something we have observed previously, for example, rods lacking Prph2 have no ERG function or OS structures, while cones lacking Prph2 retain some function and open OS structures that lack lamellae (27) . It is not clear what the different role of Rom1 is in rods versus cones to account for these different protein levels in the presence of complex-inhibiting Prph2 mutations like C150S since Rom1 retains the ability to interact with C150S-Prph2 in both rods and cones. However, we have previously observed rod-cone differences in the behavior of Rom1 in the presence of Prph2 mutations. In the case of the D2-loop mutant R172W (which causes cone-dominant MD in patients and mouse models) (25, 28, 29) , we find that Rom1, in cones, is incorporated into abnormal, very high molecular weight Prph2 complexes (25) .
Our data suggest that rods and cones can be differentially affected by Prph2 mutations that affect complex formation, and that deviations in the way that rods versus cones respond to altered complex formation may contribute to cell-specific differences in disease phenotypes. Studies on models of PRPH2-associated disease are consistent with this hypothesis. Studies on transgenic mouse lines carrying RP-causing mutations such as C214S or P216L (30, 31) have suggested that rod-targeting mutations in Prph2 act by a haploinsufficiency-based mechanism, either owing to loss-of-function or dominant negative effects. In contrast, mutations that cause cone-dominant or macular defects appear to cause disease by more complex mechanisms. Like C150S, several cone-dominant disease mutations induce various alterations in Prph2/Rom1 complex formation including R172W, K153del, and Y141C (17, 19, 20, 25, 28, 32) . While the C150S mutation causes a complete loss of higherorder complexes owing to the lack of the stabilizing disulfide bond, other mutations cause more subtle alterations in complex formation. For example, the R172W Prph2 mutation induces the formation of abnormal intermediately sized complexes containing Rom1, while the Y141C mutation leads to the formation of abnormal large-sized disulfide linked Prph2/Rom1 complexes. On the other hand, the K153del mutation affects complex formation and leads to other phenotypes similar to C150S, namely cone-dominant ERG defects and a lack of higher-order, disulfide-linked complexes (20) . Together, these studies show that proper assembly of Prph2/Rom1 oligomers is critical for the formation of rod and cone OSs, and cones especially are more sensitive to subtle changes in these complexes.
One of the key findings here is that 'supplementation' of the C150S model with large molecular weight complexes, albeit abnormal ones (e.g. from the Y141C in the Prph2 . The Y141C mutation causes the formation of abnormal large disulfide-linked complexes, while the C150S mutation ablates them, and when expressed alone, C150S (Prph2 Here we observe a haploinsufficiency phenotype in rods expressing the C150S mutation, that is, similar rod function in Prph2 þ/À and Prph2
, yet Prph2 protein levels in the Prph2 C/þ are much higher than in the Prph2 þ/À . Based on our earlier studies using a transgene that over-expresses WT Prph2 wherein we showed levels above 60% of WT have the ability to form fully functional OSs (14), we conclude that the Prph2 C/þ retina contains enough Prph2 protein ($80%) to support normal rod function. Nevertheless, rod function in the Prph2 C/þ is severely compromised, suggesting that the C150S protein is nonfunctional in rods. Yet it may be partially functional since scotopic ERG recordings are not different between Prph2 þ/À and Prph2 C/þ animals and OS ultrastructure is improved in the
. Disc stacking, orientation and size are all improved in the Prph2 C/þ compared with Prph2 þ/À . We have previously observed this improvement in rod structure but not function in another one of our Prph2 mutants with abnormalities in complex formation, the Y141C (17) . The absence of functional improvement in the face of structural improvement suggests that these OSs have less efficient phototransduction signaling than WT OSs. Abnormally large (as in the Y141C model) and abnormally small (as in the C150S model) Prph2 complexes are likely to lead to subtle alterations in rim strength and rigidity that may impair transduction of the light induced signal between the disc and the plasma membrane. Photoreceptor OSs rely on precise spatiotemporal organization for optimal phototransduction. For example, recent data indicate that cGMP-gated channels are concentrated in regions of the plasma membrane near areas of cGMP production (33).
PDE6, the protein responsible for hydrolyzing cGMP during phototransduction has been shown to translocate laterally from the rim region of the disc towards the center of the disc, a process thought to be important for changing rod sensitivity (34) . In addition, a variety of key phototransduction components including PDE6, RGS-9, R9AP and the transducin alpha subunit are known to translocate to specialized detergent-resistant membrane (DRM) domains which do not contain Prph2/Rom1 (35) in response to light (36, 37) . These results highlight the extremely precise organization of transmembrane and membraneassociated proteins in the OS. Thus it is possible that Prph2 mutants that affect the structure, stability or rigidity of the rim membrane have the potential to alter or interfere with correct light-dependent movement of OS proteins, and thus with signal transduction.
In conclusion, these studies have significantly advanced our understanding of the role of large molecular weight Prph2 complexes, their divergent requirements in rods versus cones, and the consequences of eliminating or reducing them. Cones in particular can be improved by supplementation with large molecular weight Prph2 complexes, even abnormal ones, in spite of persistent Prph2 haploinsufficiency. In addition, we find that rod disc sizing and stacking can proceed even in the presence of reduced higher-order Prph2 oligomers, provided sufficient Prph2 is present, but that full OS function likely depends on the formation of a full complement of covalently linked Prph2 oligomers. Future studies will likely continue to focus on rod versus cone differences in the utilization of Prph2 and Rom1, particularly given the relative lack of attention paid to Rom1 thus far. The widely varying and untreatable rod and conedominant patient diseases associated with Prph2 mutations highlight the need for further investigations to understand pathogenic mechanisms associated with photoreceptor degeneration.
Materials and Methods
Animals
The Prph2 C150S knock-in mouse model (Prph2 C/C ) was generated by inGenious Targeting Laboratory, Inc. (Ronkokoma, New York, NY, USA). A 10.14 kb region of genomic DNA was used from a bacterial artificial chromosome (BAC) clone identified earlier for another Prph2 knock-in mouse line to construct the targeting vector (17, 19) . The LoxP/FRT-neomycin selection cassette was inserted in intron 1383 bp downstream of Prph2 Exon 1 (which houses the C150S point mutation). The long-homology arm extended 6.9 kb 5 0 from the site of the mutation in Exon 1 while the short-homology arm extended 2.7 kb 3 0 of the end of the Neo cassette (for further information please see Supplementary Material, Fig. S1 ). The C150S point mutation (TGC to AGC) was introduced into the vector via PCR and sequencing confirmed that no other mutations were added. The BAC was sub-cloned into a 2.45 kb pSP72 (Promega, Madison, WI, USA) backbone vector (final target construct 14.3 kb), linearized with Not1 and electroporated into embryonic stem (ES) cells. The ES cells were subsequently screened for the presence of mutated Prph2 allele and positive clones were injected into C57BL/6 blastocysts. These blastocysts were implanted and subsequent chimeric founders were bred to identify mice with germline transmission. To remove the Neo cassette, the mice were bred to FLPeR expressing mice (Stock#003946, Jackson Labs, Bar Harbor, ME, USA). The Prph2 N229S (Prph2 
Ultrathin sections for EM and IG labeling
Whole eyes were fixed in EM fixative (155 mM sodium cacodylate, 2 mM CaCl 2 , 2% paraformaldehyde and 2% glutaraldehyde) or in IG fixative (1Â PBS, pH 7.4, 2% paraformaldehyde and 0.1% glutaraldehyde) for 2 h as described previously (20, 38) . The cornea and lens were removed and the eye cups were embedded in Spurr's resin. Ultrathin sections (600-800 Å ) were obtained with a glass or diamond knife on a Reichert-Jung Ultracut E microtome and collected on copper (EM) or nickel (IG) 75/300 mesh grids. Sections for EM analysis were stained with 2% (w/v) uranyl acetate and Reynold's lead citrate. Sections for IG were incubated in primary antibodies at the indicated above dilutions and in secondary antibodies (AuroProbe V R 10 nm goldconjugated goat anti-rabbit or anti-mouse IgG) at 1:50.
Electroretinography
Full-field ERG recordings were performed as described previously (19, 25) . Briefly, mice were dark-adapted overnight and then anesthetized with 85 mg/kg body weight ketamine and 14 mg/kg body weight xylazine (Butler Schein Animal Health, Dublin, OH, USA). Eyes were dilated with a 1% cyclogyl solution (Pharmaceutical Systems, Inc., Tulsa, OK, USA) and platinum wire loop electrode was placed on the cornea on a thin layer of methylcellulose (Pharmaceutical Systems, Inc. 
RNA preparation and analysis
RNA was extracted from flash frozen retinas as described previously using TRIzol (Life Technologies) (24, 27) . Reverse transcription was performed using oligo dT primers and superscript III reverse transcriptase (Life Technologies) and the cDNA was used for qRT-PCR with SYBR V R Green on a C1000 Thermal Cycler (Biorad Laboratories, Hercules, CA, USA). All the values were normalized to the housekeeping gene HPRT. Primer sequences are listed in Supplementary Material, Table S1 .
Protein extraction, IP and velocity sedimentation
Retinas were collected, flash frozen and stored at -80 C. For in vitro expression, HEK293 cells grown in DMEM (Life Technologies, Grand Island, NY, USA) with antibiotic/antimycotic solution (Corning Cellgro, Corning, NY, USA) and 5% fetal bovine serum were transfected with equimolar amounts of the following vectors: pKH3-Prph2-myc, pKH3-Prph2-Flag, pKH3-Prph2-C150S-myc and pKH3-Prph2-Y141C-flag. The DNA was added to 500 ll of a 250 mM CaCl 2 solution and an equal amount of 2Â BBS (50 mM BES, 280 mM NaCl, 1.4 mM Na2HPO4, pH 6.96) was added while vortexing. The transfection mixture was incubated at room temperature for 20 min and then added to the cells. Cells were harvested after 48 h. Retinal proteins were extracted as described previously (17, 19) . Briefly, Cell lysates or retinas were collected in extraction buffer [PBS, pH 7.0, containing 1% (v/v) Triton X-100, 5 mM EDTA, 5 mg/ml N-ethyl maleimide and protease inhibitors], briefly sonicated, and insoluble material was removed by centrifugation. For quantification of protein levels, 10% SDS-PAGE gels were run with equal amounts of retinal protein (30 mg) and blotted on PVDF membrane using standard protocols. Protein detection was performed with the antibodies mentioned above and membranes were imaged with a ChemiDoc TM MP imaging system (Biorad). Densitometric analysis of the bands was performed on non-saturated bands with Image Lab software v4.1 (Biorad) and band intensities were normalized to beta-actin in the same lane. For IP, 100 mg aliquot of total retinal proteins was used for WT retinas, and owing to the low amount of Prph2 and Rom1 in Prph2 C/C retinas, 600 mg aliquot of total retinal proteins was used as input for the mutant genotypes. For expressed protein from HEK293 cells, 200 mg protein aliquot was used as input. Briefly, the protein extract was incubated with anti-RDS-CT, Myc or Flag antibodies and protein A sepharose beads (GE Healthcare, Houston, TX, USA) or anti-Rom1-2H5 antibody conjugated to protein B sepharose beads (GE Healthcare). The bound protein was eluted with 2% SDS. A total of 7.5 mg of input (45 mg in case of Prph2 C/C ), an equivalent amount of flow through, and half of the eluent from the beads were analyzed by SDS-PAGE/western blotting.
Velocity sedimentation was performed as described previously on 5-20% sucrose gradients (28) . For WT retinas, 200 mg of retinal extract (obtained as described above) was used for the Prph2 C/C genotype extracts from two whole retinas were used per sedimentation. Sedimentations were repeated at least five times for each genotype.
Statistical analysis
For statistical analysis and graphical depiction of the data, GraphPad Prism 5 (GraphPad software, Inc., La Jolla, CA, USA) was used. All datasets were analyzed with a one-way ANOVA (after verifying that samples conformed to a Gaussian distribution) to identify significant differences between groups (P < 0.05) with correction for multiple testing. For the identification of specific differences between two groups, Tukey's posttest was used for pairwise comparison. Graphs were drawn in GraphPad Prism and plotted as means plus or minus standard error of the mean (SEM).
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